Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Compared to the overall cohort, older adults (>55 yr) had lower Sestrin2 levels (median 1.7 vs 1.8 ng/mL, p = .011), lower FN T-scores (median −1.0 vs −0.5, p < .001), higher BMI (median 30.7 vs 29.4 kg/m2, p < .001), lower eGFR (median 92.2 vs 110.5 mL/min/1.73 m2, p < .001), higher serum corrected calcium (median 2.37 vs 2.33 mmol/L, p < .001), and higher serum 25OHD (median 23.0 vs 16.0 ng/mL, p < .001).
Source: Participant characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Age and sex modify the association between plasma Sestrin2 and bone mineral density: a cross-sectional study
Source: Article title.
For the present cross-sectional analysis, data and stored plasma samples for 1000 participants were requested.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Age and sex modify the association between plasma Sestrin2 and bone mineral density: a cross-sectional study
Cross-sectional study · JBMR Plus · 2026
Original publication title
Age and sex modify the association between plasma Sestrin2 and bone mineral density: a cross-sectional study
© The Author(s) 2026. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
Sestrin2 is a stress-inducible protein that plays a significant role in maintaining antioxidant balance and metabolic homeostasis via the AMPK/mTOR pathways. Animal models suggested that Sestrin2 deficiency may be associated with high bone mass; however, how this may translate into humans, especially in aging and stress conditions, is unknown. We performed a cross-sectional analysis of 910 adults recruited from the Qatar Biobank cohort. Participants were stratified into 3 groups: younger than 40 yr, 40-55 yr, and older than 55 yr.
We investigated the relationship between plasma Sestrin2 and FN BMD T-score in adults using multiple linear regression, controlling for age, sex, BMI, diabetes, and estimated glomerular filtration rate. We observed a significant interaction between Sestrin2 and age (p < .001). In younger and middle-aged adults, Sestrin2 was not correlated with BMD. However, in adults aged >55 yr, Sestrin2 was strongly and positively correlated with FN T-scores (β = .131, 95% CI: 0.062-0.201, p < .001). This association remained significant after adjustment for all possible confounders, with an effect size reduction of only 7.7%.
Further analysis showed that this association is more pronounced in males (β = .155, p < .001) but is not significant in females (β = −.008, p = .935). Our study indicates that Sestrin2 and BMD are significantly correlated but only in aged adults. In contrast to animal models, we showed that Sestrin2 in aged adults is positively correlated with bone density. This suggests that Sestrin2 may serve as a biomarker of resilience against aging-induced stress and osteosenescence. Furthermore, this resilience mechanism appears to be sex-specific, offering protective effects primarily in aging males, likely due to differences in hormonal preservation.
Authors’ abstract
Abstract
Sestrin2 is a stress-inducible protein that plays a significant role in maintaining antioxidant balance and metabolic homeostasis via the AMPK/mTOR pathways. Animal models suggested that Sestrin2 deficiency may be associated with high bone mass; however, how this may translate into humans, especially in aging and stress conditions, is unknown. We performed a cross-sectional analysis of 910 adults recruited from the Qatar Biobank cohort. Participants were stratified into 3 groups: younger than 40 yr, 40-55 yr, and older than 55 yr.
We investigated the relationship between plasma Sestrin2 and FN BMD T-score in adults using multiple linear regression, controlling for age, sex, BMI, diabetes, and estimated glomerular filtration rate. We observed a significant interaction between Sestrin2 and age (p < .001). In younger and middle-aged adults, Sestrin2 was not correlated with BMD. However, in adults aged >55 yr, Sestrin2 was strongly and positively correlated with FN T-scores (β = .131, 95% CI: 0.062-0.201, p < .001). This association remained significant after adjustment for all possible confounders, with an effect size reduction of only 7.7%.
Further analysis showed that this association is more pronounced in males (β = .155, p < .001) but is not significant in females (β = −.008, p = .935). Our study indicates that Sestrin2 and BMD are significantly correlated but only in aged adults. In contrast to animal models, we showed that Sestrin2 in aged adults is positively correlated with bone density. This suggests that Sestrin2 may serve as a biomarker of resilience against aging-induced stress and osteosenescence. Furthermore, this resilience mechanism appears to be sex-specific, offering protective effects primarily in aging males, likely due to differences in hormonal preservation.
Publication and source details
Original title: Age and sex modify the association between plasma Sestrin2 and bone mineral density: a cross-sectional study
Muhammad Ammar Zahid; Hanan H Abunada; Ruaa Ahmed; Eiman Elamin; Hicham Raïq; Atiyeh M Abdallah; Abdelali Agouni
JBMR Plus · 2026
Corresponding author: Abdelali Agouni, Department of Pharmaceutical Sciences, College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar (aagouni@qu.edu.qa).© The Author(s) 2026. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Qatar National Research Fund10.13039/100008982 NPRP14S-0406-210150Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:57:02.996683+00:00
DOI: 10.1093/jbmrpl/ziag127 · PMC13537442